NAOS Bioderma: The latest figures, news and market research on NAOS Bioderma

Turnover: 537 million EUR (2020)

Country: France

Bioderma is part of the Naos group (Bioderma, Institut Esthederm, Etat Pur).
Bioderma is a privately-owned French pharmaceutical company specializing in medicines for dermatological and hair/scalp disorders, as well as pediatrics and cell regeneration.
The company's core business is dermatology, with products such as ABCDerm, Atoderm, Cicabio, Créaline, Hydrabio, Matriciane, Matricium, Sébium, White Objective, Secure (skin care), Nodé (hair care) and Photoderm (sun care).

Maos: Bioderma and Esthederm continue their international expansion 10/06/2021

Laboratoires Naos designs and manufactures cosmetics for three brands: Esthederm, Etat Pur and Bioderma.
77% of sales are generated internationally, mainly in Asia.
Sales in 2020: 537 million euros.
Presence in around 100 countries with 45 subsidiaries
3,000 employees in total, including 1,000 in France
13% annual growth over the past 10 years.

Bioderma and Esthederm continue their international expansion 10/06/2021

Laboratoires Naos designs and manufactures three cosmetics brands: Esthederm, Etat Pur and Bioderma.
Sales of 537 million euros in 2020.
Presence in around 100 countries with 45 subsidiaries.
3,000 employees in total (1,000 in France).
Annual growth of 13% over the past 10 years.
Bioderma accounts for 90% of the company's sales
77% of sales are generated internationally, with a strong presence in Asia.
a total of 450 people are employed in Aix-en-Provence

may 18, 2021 - Naos Group performance - source(Naos)

DUNS: 535236418

Legal Name: NAOS

Address: 355 RUE PIERRE SIMON LAPLACE , 13290 AIX-EN-PROVENCE

Number of employees: Entre 250 et 499 salariés (2020)

Capital: 43 474 650 EUR

Financial Data:

Year	2021	2020	2019	2018	2017	2016	2015
Turnover	287 426 849	238 608 313	256 352 379	224 971 900	208 608 224	171 960 474	7 854 275
Gross margin (€)	181 063 123	127 361 545	148 485 964	140 712 574	124 782 074	97 056 822	-
EBITDA (€)	44 454 969	21 438 562	24 197 961	17 094 358	21 363 701	10 195 704	-
Operating profit (€)	32 896 546	10 412 277	14 589 698	7 681 229	13 236 983	4 909 698	-
Net profit (€)	40 069 132	25 219 133	26 051 730	20 962 022	33 223 519	17 895 131	10 564 300
Turnover growth rate (%)	20,5	-6,9	13,9	7,8	21,3	2 089,4	-
Ebitda margin rate (%)	15,5	9	9,4	7,6	10,2	5,9	-
Operating margin rate (%)	11,4	4,4	5,7	3,4	6,3	2,9	-
Working Capital (turnover days)	143,9	122,4	89,1	153,4	107,9	113,7	-
Working Capital requirements (turnover days)	110,2	119,7	107,5	146	51	98,8	-
Net margin (%)	13,9	10,6	10,2	9,3	15,9	10,4	-
Added value / Turnover (%)	28,3	22,9	23,8	21,3	21	16,7	-
Wages and social charges (€)	23 175 833	20 215 634	22 071 638	20 593 642	19 637 708	15 742 366	-
Salaries / Turnover (%)	8,1	8,5	8,6	9,2	9,4	9,2	-

Company Managers:

Position	First Name	Last Name	Age
Président	Jean-Noël	THOREL	76
Directeur général	Xavier Hubert Robert Germain	UNKOVIC	58
Directeur général délégué	Thomas	PIERLOT	48
Directeur général délégué	Pascal	GOUYET	58
Directeur général délégué	Boris, William	AUGUSTE	57
Directeur général délégué	David, Christophe, Philippe	DURAND	49